Novavido is a technological society funded in 2021 and focused on the development of a new medical device based on nanotechnologies to recover the vision in blind patients affected by retinitis pigmentosa
We work on a disruptive technology born from a 10-years collaboration between the Italian Institute of Technology and the hospital IRCCS Sacro Cuore Don Calabria di Negrar.
![](https://www.novavido.it/wp-content/uploads/2021/10/istituto-italiano-tecnologia.png)
![](https://www.novavido.it/wp-content/uploads/2021/10/sacro-cuore.png)
Our device, liquid retina, can potentially substitute photoreceptors damaged by retina degenerations and recover the vision in the whole field of view.
Currently, we have tested our device on a model of retinitis pigmentosa up to 9 months after the implantation and we have proved its efficacy in recovering the visual function.